PA 2120 Pill - white capsule/oblong, 19mm
Pill with imprint PA 2120 is White, Capsule/Oblong and has been identified as Valproic Acid 250 mg. It is supplied by Teva Pharmaceuticals USA.
Valproic acid is used in the treatment of Bipolar Disorder; Epilepsy; Seizure Prevention; Headache; Seizures and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Valproic acid 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for PA 2120



Valproic Acid
- Imprint
- PA 2120
- Strength
- 250 mg
- Color
- White
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Fatty acid derivative anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk - When treating epilepsy, X - Not for use in pregnancy - When treating migraine
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 50111-0852 (Discontinued)
- Inactive Ingredients
-
corn oil,
FD&C Blue No. 1,
gelatin,
glycerin,
water,
titanium dioxide
Note: Inactive ingredients may vary.
More about valproic acid
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (64)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: fatty acid derivative anticonvulsants
- Breastfeeding
- En español
Patient resources
- Valproic acid drug information
- Valproic acid (Advanced Reading)
- Valproate Injection
- Valproic Acid Capsules
- Valproic Acid Liquid
Other brands
Valproate Sodium, Depakene, Depacon, Stavzor
Professional resources
- Valproic Acid monograph
- Valproate (FDA)
- Valproic Acid Capsules (FDA)
- Valproic Acid Oral Solution (FDA)
- Valproic Acid Syrup (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.